Hydroxyurea-induced leg ulceration in 14 patients
- PMID: 9424978
- DOI: 10.7326/0003-4819-128-1-199801010-00005
Hydroxyurea-induced leg ulceration in 14 patients
Abstract
Background: Hydroxyurea is an antineoplastic agent commonly used to treat myeloproliferative disorders and other nonneoplastic conditions.
Objective: To further define the typical features of hydroxyurea-related cutaneous ulcers of the leg.
Design: Retrospective, descriptive study of the medical records of patients who developed leg ulcers while receiving hydroxyurea therapy.
Setting: A tertiary care medical center.
Patients: Patients with myeloproliferative disorders who were treated with hydroxyurea.
Results: 14 patients with extremely painful leg ulcers were identified. The most common ulcer site was the malleoli. Multiple ulcers were seen in 64% of patients. Patients had received hydroxyurea for an average of 6 years before ulcers developed. All ulcers healed after discontinuation of hydroxyurea treatment, and 2 patients developed ulcers after treatment was restarted.
Conclusion: Hydroxyurea induces painful leg ulcers that are usually difficult to treat and require cessation of hydroxyurea therapy.
Comment in
-
Hydroxyurea-associated leg ulceration.Ann Intern Med. 1998 Aug 1;129(3):252; author reply 252-3. doi: 10.7326/0003-4819-129-3-199808010-00017. Ann Intern Med. 1998. PMID: 9696737 No abstract available.
-
Hydroxyurea-associated leg ulceration.Ann Intern Med. 1998 Aug 1;129(3):252-3. doi: 10.7326/0003-4819-129-3-199808010-00018. Ann Intern Med. 1998. PMID: 9696738 No abstract available.
-
Hydroxyurea-induced leg ulcers treated with Apligraf.Ann Intern Med. 2000 Mar 7;132(5):417-8. doi: 10.7326/0003-4819-132-5-200003070-00017. Ann Intern Med. 2000. PMID: 10691597 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical